Severe Hypoglycemia Monitoring and Risk Management Procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial-Reference-Cited by-同舟云学术

Severe Hypoglycemia Monitoring and Risk Management Procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

Published:2007-06 Issue:12 Volume:99 Page:S80-S89
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Bonds Denise E.,Kurashige Ella Mae,Bergenstal Richard,Brillon David,Domanski Michael,Felicetta James V.,Fonseca Vivian A.,Hall Kathleen,Hramiak Irene,Miller Michael E.,Osei Kwame,Simons-Morton Denise G.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference13 articles.

1. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes;Bulsara;Diabetes Care,2004

2. Hypoglycemia in type 2 diabetes: a critical review;Murata;Biomed Pharmacother,2004

3. Banting Lecture;Cryer;Diabetes,1994

4. Hypoglycemia as a barrier to glycemic control;Davis;J Diabetes Complications,2004

5. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods;Am J Cardiol,2007

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac autonomic neuropathy modified the association between obesity and hypoglycemia in type 2 diabetes;Endocrine;2024-06-21

2. Hypoglycemic episodes among type 1 diabetic patients in Unaizah, Saudi Arabia: causes, management, and associated factors;Diabetes mellitus;2024-02-29

3. Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition);AGING MEDICINE;2024-02

4. Efficacy and safety of intensive versus conventional glucose targets in people with type 2 diabetes: a systematic review and meta-analysis;Expert Review of Endocrinology & Metabolism;2023-01-02

5. Autonomic dysfunction and risk of severe hypoglycemia among individuals with type 2 diabetes;JCI Insight;2022-11-01